US › Healthcare

DarioHealth Corp (DRIO)

US · Healthcare · Health Information Services

$6.87-3.24%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$5.6M
Revenue YoY
-17.3%
Net profit
$-8.2M
Profit YoY
+10.6%
EPS
$-0.95
EPS estimate
$-0.85
Net margin
-147.7%

EPS came in at -0.95 against a street estimate of -0.85 — a miss of 11.8%.

Key statistics

Market cap
$69.2M
Forward P/E
10.6
P/B
1.14
Book value
$8.55
EPS (TTM)
$-8.50
52-week high
$17.74
52-week low
$5.84
50-day MA
$7.17
200-day MA
$9.77
Beta
1.12

Analyst view

Analysts rate DarioHealth Corp a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $15.25.

Shareholding

Insiders
15.89%
Institutions
8.98%

Largest institutional holders

FundStake
Nantahala Capital Management, LLC8.35%
Vanguard Capital Management, LLC0.90%
Geode Capital Management, LLC0.85%
Vanguard Fiduciary Trust Co0.41%
Citadel Advisors Llc0.28%
BlackRock Inc0.26%
UBS Group AG0.22%
Northern Trust Corp0.18%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for DarioHealth Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.